IRVINE, Calif.--(BUSINESS WIRE)--Reverse Medical Corporation today announced that it has sold its line of neurovascular guide catheters to Covidien, a leading global provider of healthcare products. The terms of the transaction were not disclosed.

"Despite being a young company, Reverse Medicals guide catheter business already includes a strong customer base, manufacturing platform, and suite of products and technologies. The lead product, ReFlex™, has been a great commercial success for us," said Jeffrey Valko, President and CEO of Reverse Medical.

Reverse Medical will retain possession of its thrombectomy technologies and products and will continue its innovative development of new technologies for the treatment of neurovascular disorders, including both ischemic and hemorrhagic stroke.

Brian Strauss, Reverse Medicals Chief Technology Officer added, "This transaction validates our ability to listen to our customer needs and rapidly develop and commercialize technologies specifically designed for the treatment of neuro endovascular disorders."

About Reverse Medical

Reverse Medical Corporation was founded in 2007 by the MedFocus Fund, and is a privately-held medical device company focused on expanding the endovascular management of acute stroke and neurovascular disease. The technology platform includes innovative, state-of-the-art treatments for a broad spectrum of neurovascular disorders and carotid artery disease. The company is based in Irvine, California.

Posted by Sean Fenske, Editor-in-Chief, MDT